Brain Navi Biotechnology Co., Ltd. is teaming up with BenQ Medical Technology Corporation to introduce and commercialize the NaoTrac neurosurgical navigation robot in the Chinese market. 

Why it matters: 

• China’s surgical robotics market is projected to hit $9.5B by 2030   
• BenQ Medical’s hospital network boosts clinical adoption   
• NaoTrac has been used in some medical centers across Asia, Latin America, and Europe.  

Brain Navi CEO Jerry Chen: “Localization is key—this partnership helps accelerate neurosurgical robotics adoption in China.”  

Follow Globalbio for more exclusive biotech insights!  
https://news.gbimonthly.com/tw/article/show.php?num=75561

#Neurosurgery #Robotics #AIHealthcare #BrainNavi #BenQMedical #SurgicalInnovation